Friday, June 27, 2025 8:14:32 PM
Not really, NWBio did not use any Real World Data (RWD) or Real World Evidence (RWE) in their Phase III DCVax-L clinical trial.
Instead they used an External Control Arm (ECA) comprised of pooled control group data from other contemporaneous randomized controlled trials (RCTs).
Data from RCTs is neither RWD nor RWE.
RWD refers to health-related information gathered outside of the traditional, controlled clinical trial setting. It encompasses data routinely collected during the delivery of healthcare, such as from electronic health records, insurance claims, and patient-generated data from wearable devices. This data provides insights into how a treatment or product performs in real-world clinical practice, among a more diverse patient population, and in real-world settings.
RWE refers to clinical evidence about the use, benefits, and risks of medical products derived from analyzing real-world data (RWD).
Instead they used an External Control Arm (ECA) comprised of pooled control group data from other contemporaneous randomized controlled trials (RCTs).
Data from RCTs is neither RWD nor RWE.
RWD refers to health-related information gathered outside of the traditional, controlled clinical trial setting. It encompasses data routinely collected during the delivery of healthcare, such as from electronic health records, insurance claims, and patient-generated data from wearable devices. This data provides insights into how a treatment or product performs in real-world clinical practice, among a more diverse patient population, and in real-world settings.
RWE refers to clinical evidence about the use, benefits, and risks of medical products derived from analyzing real-world data (RWD).
Bullish
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM

